400
Participants
Start Date
August 31, 2013
Primary Completion Date
December 31, 2014
Study Completion Date
February 28, 2015
Compound Edaravone Injection
Edaravone Injection
Navy General Hospital of The Chinese PLA, Beijing
Beijing Tiantan Hospital affiliated to Capital Medical University, Beijing
Peking University Third Hospital, Beijing
The General Hospital of Shenyang Military, Chinese PLA, Shenyang
The Second Affiliated Hospital of Haerbin Medical University, Haerbin
Shanghai Changzheng Hospital, Shanghai
Rui Jin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai
Nanjing First Hospital, Nanjing
The Second Affiliated Hospital of Nanjing Medical University, Nanjing
Nanjing Brain Hospital, Nanjing
The Affiliated Hospital of Xuzhou Medical College, Xuzhou
Qilu Hospital of Shandong University, Jinan
The Second Hospital of Shandong University, Jinan
Qingdao Municipal Hospital, Qingdao
Tianjin People's Hospital, Tianjin
Tianjin Medical University General Hospital, Tianjin
Tianjin Huanhu Hospital, Tianjin
Jiangxi Provincial People's Hospital, Nanchang
The First Affiliated Hospital of Chongqing Medical University, Chongqing
The First Affiliated Hospital of Third Military Medical University of Chinese PLA, Chongqing
Hunan Provincial People's Hospital, Changsha
The First Affiliated Hospital of Sun Yat-sen University, Guangzhou
Peking University Shenzhen Hospital, Shenzhen
The Second Hospital of Hebei Medical University, Shijiazhuang
Hebei General Hospital, Shijiazhuang
Central Hospital of Baotou, Baotou
The First Affiliated Hospital of Shanxi Medical University, Taiyuan
The Second Affiliated Hospital of Shanxi Medical University, Taiyuan
Lead Sponsor
Jiangsu Simcere Pharmaceutical Co., Ltd.
INDUSTRY